As of 2026-09-25, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 21.12 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 42.21 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is -50.0%.
The range of the Relative Valuation is 16.89 - 25.34 CAD.
| Range | Selected | |
| Trailing P/E multiples | 9088.2x - 13628.0x | 11358.1x |
| Forward P/E multiples | 9094.8x - 13632.4x | 11363.6x |
| Fair Price | 16.89 - 25.34 | 21.12 |
| Upside | -60.0% - -40.0% | -50.0% |
| Date | P/E |
| 2026-09-23 | 22,707.78 |
| 2026-09-22 | 22,826.13 |
| 2026-09-21 | 22,390.37 |
| 2026-09-18 | 21,249.88 |
| 2026-09-17 | 20,953.99 |
| 2026-09-16 | 20,012.54 |
| 2026-09-15 | 19,302.42 |
| 2026-09-14 | 19,054.95 |
| 2026-09-11 | 20,566.65 |
| 2026-09-10 | 19,770.45 |
| 2026-09-09 | 20,475.20 |
| 2026-09-08 | 19,630.58 |
| 2026-09-04 | 19,474.57 |
| 2026-09-03 | 18,183.44 |
| 2026-09-02 | 17,984.39 |
| 2026-09-01 | 18,328.69 |
| 2026-08-31 | 18,484.70 |
| 2026-08-28 | 18,925.84 |
| 2026-08-27 | 21,050.83 |
| 2026-08-26 | 21,378.99 |
| 2026-08-25 | 21,029.31 |
| 2026-08-24 | 20,023.30 |
| 2026-08-21 | 20,711.90 |
| 2026-08-20 | 21,868.54 |
| 2026-08-19 | 20,706.52 |
| 2026-08-18 | 18,866.66 |
| 2026-08-17 | 20,485.96 |
| 2026-08-14 | 19,393.87 |
| 2026-08-13 | 19,431.53 |
| 2026-08-12 | 18,990.39 |
| 2026-08-11 | 18,554.64 |
| 2026-08-10 | 18,242.61 |
| 2026-08-07 | 19,124.89 |
| 2026-08-06 | 18,441.66 |
| 2026-08-05 | 18,447.04 |
| 2026-08-04 | 19,135.65 |
| 2026-07-31 | 16,408.13 |
| 2026-07-30 | 16,036.93 |
| 2026-07-29 | 14,299.28 |
| 2026-07-28 | 15,251.49 |
| 2026-07-27 | 16,548.00 |
| 2026-07-24 | 17,005.28 |
| 2026-07-23 | 18,312.55 |
| 2026-07-22 | 18,495.46 |
| 2026-07-21 | 18,210.34 |
| 2026-07-20 | 17,080.60 |
| 2026-07-17 | 16,542.62 |
| 2026-07-16 | 16,526.49 |
| 2026-07-15 | 18,048.94 |
| 2026-07-14 | 19,490.71 |